Industry Reports
Novartis announces phase II SUSTAIN study of SEG101 significantly...
Results from the Phase II SUSTAIN study show that SEG101 (crizanlizumab, formerly SelG1), an anti-P-selectin antibody, reduced the median annual rate of sickle cell-related pain...
Industry Reports
Aegerion Pharmaceuticals INC and QLT INC Complete Merger Transaction...
Aegerion Pharmaceuticals Inc and QLT Inc announced the completion of their merger transaction, as a result of which Aegerion is now an indirect wholly-owned subsidiary...
Industry Reports
Catalent Acquires Accucaps To Expand Softgel Development And Manufacturing...
Catalent Inc the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products announced that it has agreed...
Industry Reports
Arrow Generiques to acquire select assets in France from...
Arrow Generiques SAS, the French subsidiary of Aurobindo Pharma Ltd announced the signing of an agreement to acquire select commercial products in France from Teva....
Industry Reports
GSK Starts Phase III Programme with Daprodustat for Anemia...
GlaxoSmithKline plc announced the start of a phase III development programme investigating daprodustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), as a treatment for...
Industry Reports
Lilly Announces Top-Line Results of Solanezumab Phase 3 Clinical...
Eli Lilly and Company announced that solanezumab did not meet the primary endpoint in the EXPEDITION3 clinical trial, a phase 3 study of solanezumab in...
Industry Reports
Sun Pharma to acquire Biosintez in Russia
Sun Pharma announced the execution of definitive agreements by its wholly owned subsidiary, for the acquisition of 85.1% of JSC Biosintez, a Russian pharmaceutical company...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.